To monitor viability or proliferation, phenotypes of cell line models can be instrumental for the characterization and selection of drug candidates. Cell lines with endogenous or engineered expression of a selection biomarker (e.g., an oncogenic driver mutation) are highly informative. Examples of mechanistic cellular assays we frequently use in clients’ projects to measure cell proliferation, viability, and apoptosis include:
NUVISAN has long-standing expertise in DNA damage assays to evaluate the diverse effects of compounds and the underlying molecular mechanisms to repair DNA lesions. We offer assays for the detection, analysis, and quantification of different DNA damage associated phenotypes, as well as DNA damage repair mechanisms. This includes high-throughput layouts, such as our high-content assay platform. We also offer in vitro and in vivo X-ray irradiation capabilities for experimental DNA damage induction. Some example readouts are
Cell migration is essential for many physiological processes, including embryo development, wound repair, angiogenesis, and tumor metastasis. The scratch wound assay measures basic cell migration parameters. We use the IncuCyte® system to quantify cells with time-lapse imaging. We offer this assay with different cell types, including cancer model cell lines, primary human fibroblasts (FCs), endothelial cells (ECs), and smooth muscle cells (SMCs).
Apoptosis, or programmed cell death, is frequently disturbed in cancer cells, which means therapies leading to induction of apoptosis are highly attractive. Apoptosis is characterized by defined morphological changes, including cell shrinkage, chromatin condensation, loss of nuclear membrane integrity, plasma membrane blebbing, and the formation of apoptotic bodies. These phenotypes can be monitored to confirm the induction of apoptosis by small-molecule drugs or biologics. However, treatment with drugs can often lead to mixed phenotypes that also include necrosis in cancer cells. We offer multiple methods to assess different aspects of the apoptotic pathway and to characterize the mode of action of your compound.